(TAK) Takeda Pharmaceutical - Performance 19.6% in 12m
Compare TAK with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
5.56%
#53 in Group
Rel. Strength
74.57%
#2030 in Universe
Total Return 12m
19.64%
#41 in Group
Total Return 5y
4.20%
#63 in Group
P/E 33.4
82th Percentile in Group
P/E Forward 36.8
76th Percentile in Group
PEG 1.63
75th Percentile in Group
FCF Yield 6.78%
76th Percentile in Group
12m Total Return: TAK (19.6%) vs XLV (1.7%)

5y Drawdown (Underwater) Chart

Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: TAK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TAK
Total Return (including Dividends) | TAK | XLV | S&P 500 |
---|---|---|---|
1 Month | 2.82% | -3.79% | -0.87% |
3 Months | 14.19% | -3.99% | -7.58% |
12 Months | 19.64% | 1.72% | 11.88% |
5 Years | 4.20% | 55.40% | 110.33% |
Trend Score (consistency of price movement) | TAK | XLV | S&P 500 |
1 Month | 51.3% | -3.2% | 23% |
3 Months | 65.6% | -71.4% | -88.5% |
12 Months | 59.6% | -17.5% | 55.1% |
5 Years | -26.6% | 89.8% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
1 Month | #79 | 6.88% | 3.72% |
3 Month | #23 | 18.9% | 23.6% |
12 Month | #41 | 17.6% | 6.94% |
5 Years | #63 | -33.0% | -50.5% |
FAQs
Does TAK Takeda Pharmaceutical outperforms the market?
Yes,
over the last 12 months TAK made 19.64%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months TAK made 14.19%, while XLV made -3.99%.
Over the last 3 months TAK made 14.19%, while XLV made -3.99%.
Performance Comparison TAK vs Indeces and Sectors
TAK vs. Indices TAK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.85% | 3.69% | 11.5% | 7.76% |
US NASDAQ 100 | QQQ | -3.88% | 1.42% | 11.1% | 6.97% |
US Dow Jones Industrial 30 | DIA | -1.91% | 6.0% | 11.6% | 10.4% |
German DAX 40 | DAX | -1.62% | 1.50% | -7.98% | -5.04% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.11% | 5.64% | 14.5% | 13.7% |
Hongkong Hang Seng | HSI | -1.86% | 2.76% | 9.62% | 5.75% |
India NIFTY 50 | INDA | -0.01% | -1.24% | 11.3% | 16.6% |
Brasil Bovespa | EWZ | -2.05% | -1.78% | 7.84% | 25.5% |
TAK vs. Sectors TAK is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.10% | 3.87% | 5.41% | -4.32% |
Consumer Discretionary | XLY | -2.93% | 2.92% | 9.03% | 6.32% |
Consumer Staples | XLP | 0.65% | 2.62% | 6.23% | 8.44% |
Energy | XLE | 1.63% | 16.7% | 17.3% | 30.7% |
Financial | XLF | -1.46% | 4.93% | 3.94% | -3.05% |
Health Care | XLV | -2.77% | 6.61% | 13.2% | 17.9% |
Industrial | XLI | -3.27% | 2.71% | 10.8% | 10.1% |
Materials | XLB | -2.24% | 5.25% | 19.0% | 23.2% |
Real Estate | XLRE | -1.33% | 4.13% | 12.4% | 1.55% |
Technology | XLK | -5.30% | 1.13% | 14.9% | 11.9% |
Utilities | XLU | -0.01% | 2.76% | 9.42% | -2.19% |
Aerospace & Defense | XAR | -3.80% | -3.57% | -1.99% | -6.93% |
Biotech | XBI | -4.15% | 0.54% | 24.2% | 21.5% |
Homebuilder | XHB | -2.16% | 5.09% | 26.4% | 26.7% |
Retail | XRT | -1.28% | 3.38% | 17.1% | 22.4% |